Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for American Well Corporation (AMWL : NYSE)

• Company Description    American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. Number of Employees: 562

• Price / Volume Information    Yesterday's Closing Price: $10.81 Daily Weekly Monthly 20 Day Moving Average: 151,992 shares Shares Outstanding: 16.55 (millions) Market Capitalization: $178.93 (millions) Beta: 1.69 52 Week High: $13.45 52 Week Low: $3.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.63% 16.71% 12 Week 76.63% 72.30% Year To Date 120.16% 103.34%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 75 State Street Ste 100 - Boston,MA 02109 USA ph: 617-204-3500 fax: - investors@amwell.com https://business.amwell.com

• General Corporate Information    Officers Ido Schoenberg - Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Paul McNeice - Chief Accounting Officer Roy Schoenberg - Director Rivka Goldwasser - Director Peer Information American Well Corporation (HLIS) American Well Corporation (AZTA) American Well Corporation (APYI) American Well Corporation (RNVA) American Well Corporation (HMSY) American Well Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 03044L204 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 16.55 Most Recent Split Date: 7.00 (0.05:1) Beta: 1.69 Market Capitalization: $178.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.62 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.68 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.75 Price/Cash Flow: - Price / Sales: 0.75 EPS Growth vs. Year Ago Period: 54.91% vs. Previous Quarter: 45.45% Sales Growth vs. Year Ago Period: -17.88% vs. Previous Quarter: -0.77% ROE 06/30/26 - - 03/31/26 - -32.11 12/31/25 - -35.33 ROA 06/30/26 - - 03/31/26 - -24.12 12/31/25 - -26.43 Current Ratio 06/30/26 - - 03/31/26 - 3.09 12/31/25 - 3.37 Quick Ratio 06/30/26 - - 03/31/26 - 3.08 12/31/25 - 3.35 Operating Margin 06/30/26 - - 03/31/26 - -35.50 12/31/25 - -39.52 Net Margin 06/30/26 - - 03/31/26 - -37.02 12/31/25 - -38.38 Pre-Tax Margin 06/30/26 - - 03/31/26 - -36.19 12/31/25 - -37.24 Book Value 06/30/26 - - 03/31/26 - 14.51 12/31/25 - 14.97 Inventory Turnover 06/30/26 - - 03/31/26 - 70.52 12/31/25 - 60.31 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©